
Solving Patient Matching in Rare Disease Trials
Apr 29, 2026 - 00:33:36
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
After3 years in the making, the Joint Clinical Assessment for the EU is in effect. From 12th January 2025 new cancer medicines and advanced therapy medicinal products (ATMPs) will require a JCA across all 27 member state...
The JCA is live is an episode from Rare Disease, Cell & Gene Therapy Monthly RoundUp by Partners4Access. After3 years in the making, the Joint Clinical Assessment for the EU is in effect. From 12th January 2025 new cancer medicines and adva...
This episode belongs to Rare Disease, Cell & Gene Therapy Monthly RoundUp.
Use the player on this page to stream the episode online.
Published Jan 13, 2025, 00:25:24 long, audio available.
After3 years in the making, the Joint Clinical Assessment for the EU is in effect. From 12th January 2025 new cancer medicines and advanced therapy medicinal products (ATMPs) will require a JCA across all 27 member states. Join Owen and Georgie, along with guests Darren Callanan and Sam Morrison to discuss the main talking points of the JCA, and what to look out for when dealing with the new regulations.
You can listen to The JCA is live online on Radio and Podcast. Open the player on this page to stream the available audio.
The JCA is live is an episode from Rare Disease, Cell & Gene Therapy Monthly RoundUp by Partners4Access.
This episode is 00:25:24 long.
This episode was published on Jan 13, 2025.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from Rare Disease, Cell & Gene Therapy Monthly RoundUp when more episodes are available from the podcast feed.